Drugs / CNS10-NPC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04284293 | Jul 2021 → Jul 2026 overdue | retinitis pigmentosa | Cedars-Sinai Medical Center | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNS10-NPC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04284293 ↗ |
| Route | Other | “subretinal injection” NCT04284293 ↗ |